EWC vs IBB

iShares MSCI Canada ETF vs iShares Biotechnology ETF

Quick take
  • IBB has the lower expense ratio at 0.44% vs 0.50% for EWC.
  • EWC pays a higher dividend yield (1.33%).

Side-by-side metrics

MetricEWCIBB
Expense ratio
Annual fee. Lower is better.
0.50%0.44%
Dividend yield
Trailing 12-month yield.
1.33%0.23%
AUM
Assets under management — bigger funds are typically more liquid.
$5.24B$7.95B
YTD return
7.94%3.10%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.850.74
P/E ratio
19.3823.72
Last price
$57.82$170.10
Inception
Issuer
iSharesiShares

EWC top holdings

Top holdings · EWC
RYRoyal Bank of Canada8.22%
TDThe Toronto-Dominion Bank5.96%
SHOPShopify Inc Registered Shs -A- Subord Vtg4.86%
ENB.TOEnbridge Inc3.96%
BMO.TOBank of Montreal3.53%
CM.TOCanadian Imperial Bank of Commerce3.39%
CNQ.TOCanadian Natural Resources Ltd3.25%
BNS.TOBank of Nova Scotia3.15%
AEM.TOAgnico Eagle Mines Ltd3.09%
BN.TOBrookfield Corp Registered Shs -A- Limited Vtg3.05%
Sector breakdown · EWC
Real Estate0.2%
Consumer Cyclical3.8%
Basic Materials14.8%
Consumer Defensive3.3%
Technology8.4%
Communication Services0.7%
Financial Services38.1%
Utilities2.3%
Industrials9.4%
Energy19.1%

IBB top holdings

Top holdings · IBB
AMGNAmgen Inc7.37%
GILDGilead Sciences Inc7.32%
VRTXVertex Pharmaceuticals Inc7.21%
REGNRegeneron Pharmaceuticals Inc6.55%
ALNYAlnylam Pharmaceuticals Inc3.71%
ARGXargenx SE ADR3.33%
INSMInsmed Inc2.70%
BIIBBiogen Inc2.67%
NTRANatera Inc2.40%
RVMDRevolution Medicines Inc Ordinary Shares2.27%
Sector breakdown · IBB
Healthcare100.0%

About EWC

EWC (iShares MSCI Canada ETF) is Canadian large and mid-cap equities. Managed by iShares, the fund carries $5.2B in assets under management, an expense ratio of 0.50%, a dividend yield of 1.33%. Its largest holding is Royal Bank of Canada (RY), which represents 8.2% of the portfolio. Real Estate is the fund's largest sector exposure at 0.2%.

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.